The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shklyar A.A.

Federal State Budget Institution “Research Center for Obstetrics, Gynecology and Perinatology” Ministry of Healthcare of the Russian Federation, 117997, Russian Federation, Moscow, Oparin’s street, 4

Adamyan L.V.

Department of Reproductive Medicine and Surgery, Faculty of Postgraduate Professional Education, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia

Kogan E.A.

Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova, Moskva

Paramonova N.B.

FGBU "Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova" Minzdrava Rossii, Moskva;
GBOU "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova" Minzdrava Rossii, Rossiĭskaia Federatsiia

Kozachenko I.Ph.

Federal State Budget Institution “Research Center for Obstetrics, Gynecology and Perinatology” Ministry of Healthcare of the Russian Federation, 117997, Russian Federation, Moscow, Oparin’s street, 4

Gavrilova T.Yu.

Federal State Budget Institution “Research Center for Obstetrics, Gynecology and Perinatology” Ministry of Healthcare of the Russian Federation, 117997, Russian Federation, Moscow, Oparin’s street, 4

Kononov S.N.

Federal State University Scientific Center of obstetrics, gynecology and perynathology named after V.I. Kulakov, Ministry of Health of the Russian Federation, Moscow, Russia, 117997

Receptor status of endometrioid heterotopias as the indication for hormonal therapy of nodular and diffuse forms of adenomyosis

Authors:

Shklyar A.A., Adamyan L.V., Kogan E.A., Paramonova N.B., Kozachenko I.Ph., Gavrilova T.Yu., Kononov S.N.

More about the authors

Journal: Russian Journal of Human Reproduction. 2015;21(2): 88‑93

Read: 1095 times


To cite this article:

Shklyar AA, Adamyan LV, Kogan EA, Paramonova NB, Kozachenko IPh, Gavrilova TYu, Kononov SN. Receptor status of endometrioid heterotopias as the indication for hormonal therapy of nodular and diffuse forms of adenomyosis. Russian Journal of Human Reproduction. 2015;21(2):88‑93. (In Russ.)
https://doi.org/10.17116/repro201521288-93

Recommended articles:

References:

  1. Adamyan L.V., Andreeva E.N. Kliniko-geneticheskie aspekty adenomioza. Akusherstvo i ginekologiya. 1999;3:38-43.
  2. Adamyan L.V., Andreeva E.N. Genital'nyi endometrioz: etiopatogenez, klinika, diagnostika, lechenie: Metodicheskoe posobie dlya vrachei. M. 2001;35.
  3. Adamyan L.V., Zarat'yants O.V., Maksimova Yu.V., Murdalova Z.Kh. Novye patogeneticheskie aspekty rasprostranennogo infil'trativnogo endometrioza: teoriya i praktika. Problemy reproduktsii. 2010;4:31-36.
  4. Adamyan L.V., Kulakov V.I. Endometriozy. M. 1998;317.
  5. Burlev V.A., Il'yasova N.A., Gavrilova T.Yu., Adamyan L.V. Dopolnitel'nye kriterii otsenki stadii rasprostraneniya adenomioza. Problemy reproduktsii. 2006;12:6:47-52. 
  6. Ishchenko A.I., Kudrina E.A. Endometrioz: diagnostika i lechenie. M.: GEOTAR-MED 2002;104.
  7. Kira E.F., Ermolinskii E.E., Mel'ko A.I. Endometrioidnaya bolezn'. Sovremennye printsipy lecheniya. Ginekologiya. 2004;5:231-237.
  8. Kogan E.A., Nizyaeva N.V., Demura T.A., Faizullina N.M., Ezhova L.S., Unanyan A.L. Geterogennost' adenomioza. Materialy XI Vserossiiskogo nauchnogo foruma «Mat' i ditya». M. 2010;402.
  9. Sonova M.M. Kliniko-morfologicheskie, molekulyarno-biologicheskie i lechebnye faktory genital'nogo endometrioza: Dis. ... d-ra med. nauk. M. 2009;51.
  10. Coccia ME, Rizzello F. Ultrasonographic staging: a new staging system for deep endometriosis. Ann N Y Acad Sci. 2011 Mar;1221:61-69. 
  11. Haas D, Wurm P, Shamiyeh A, Shebl O, Chvatal R, Oppelt P. Efficacy of the revised Enzian classification: a retrospective analysis. Does the revised Enzian classification solve the problem of duplicate classification in rASRM and Enzian? Arch Gynecol Obstet. 2013;287(5):941-945. 
  12. Mehasseb MK, Panchal R, Taylor AH, Brown L, Bell SC, Habiba M. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis. Fertil Steril. 2011 Jun;95(7):2228-2235.
  13. Naftalin J, Hoo W, Pateman K, Mavrelos D, Foo X, Jurkovic D. Is adenomyosis associated with menorrhagia? Hum Reprod. 2014 Mar;29(3):473-479. 
  14. Palmisano GP, Adamson GD, Lamb EJ. Can staging systems for endometriosis based on anatomic location and lesion type predict pregnancy rates? Int J Fertil Menopausal Stud. 1993;38(4):241-249.
  15. Sasa H, Imai K, Suzuki A, Sei K, Makimura N, Furuya K. Comparison of low-dose dienogest with low-dose danazol for long-term treatment of adenomyosis. Obstet Gynecol. 2014 May;123:Suppl 1:97-98.
  16. Streuli I, Dubuisson J, Santulli P, de Ziegler D, Batteux F, Chapron C. An update on the pharmacological management of adenomyosis. Expert Opin Pharmacother. 2014 Sep 6;1-14.
  17. Tamaresis JS, Irwin JC, Goldfien GA, Rabban JT, Burney RO, Nezhat C, DePaolo LV, Giudice LC. Molecular Classification of Endometriosis and Disease Stage Using High-Dimensional Genomic Data. Endocrinology. 2014 Sep 22;en1490-en2014.
  18. Zhou YF. Comprehensive understanding of adenomyosis. Zhonghua Fu Chan Ke Za Zhi. 2013 Apr;48(4):291-294. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.